Subjects to be considered in partial replicate BE study [RSABE / ABEL]

posted by cher0424 – China, 2015-01-08 07:28 (3682 d 06:37 ago) – Posting: # 14243
Views: 29,505

Dear Detlew

❝ Since according to 1. a subject with two periods, each with reference, will not be included in the pharmacokinetic analysis it can't be included in the statistical analysis (of whatever) since no PK metrics are available.


Thank you for your response.
One more query, why a subject with two periods, each with reference, will not be included in the pharmacokinetic analysis for SWR?

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,666 registered users;
192 visitors (0 registered, 192 guests [including 8 identified bots]).
Forum time: 14:05 CET (Europe/Vienna)

Operational hectic replaces
intellectual calms.    Alexander Huiskes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5